Related Experiment Video
Updated: Dec 24, 2025

07:10
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
16.8K
Precision medicine in cow's milk allergy
1Allergy Unit - Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
Current Opinion in Allergy and Clinical Immunology
|April 7, 2020
Summary
Precision medicine, utilizing
Area of Science:
- 'Omics' sciences and precision medicine in immunology and allergy research.
Background:
- Cow's milk allergy (CMA) pathogenesis and mechanisms are increasingly understood through 'omics' sciences.
- Advances in food allergy research provide insights into cow's milk protein allergenicity.
Purpose of the Study:
- To elucidate the role of precision medicine in diagnosing, treating, and monitoring cow's milk allergy.
- To explore how 'omics' technologies enhance understanding and management of CMA.
Main Methods:
- Application of 'omics'-based technologies for differentiating CMA subtypes.
- Utilizing precision medicine to determine individual threshold doses via oral food challenges.
- Investigating dietary strategies and oral immunotherapy based on individual immune profiles.
Main Results:
- 'Omics' technologies aid in predicting CMA persistence and identifying patient-specific immune profiles.
- Precision medicine enables tailored interventions, including tolerance induction and optimized oral immunotherapy.
- Biomarker identification shows potential for improving diagnostic accuracy and predicting treatment response.
Conclusions:
- Precision medicine, integrating 'omics' data and patient history, allows for targeted interventions in CMA.
- Individualized immune profiles are crucial for predicting the safety and efficacy of oral immunotherapy.
- The integration of patient data and advanced technologies is key for future clinical applications in CMA management.
More Related Videos
Related Concept Videos
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions
31.7K
Overview
31.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K

